TITLE:
      Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
SUMMARY:
      The purpose of this study is to assess the abuse liability and examine the reinforcing
      effects of intravenous buprenorphine and buprenorphine/naloxone combinations in
      buprenorphine-naloxone maintained volunteers
DETAILED DESCRIPTION:
      Ongoing study - results not available at this time
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        Individuals must be at least 18 yrs of age, currently opioid dependent and meet FDA
        criteria for narcotic maintenance treatment. Co-morbid substance abuse or dependence
        disorders may also be present. Individuals must be healthy despite drug dependency and
        have a history of IV opioid use.

        Exclusion Criteria:

        Individuals with evidence of anti active Diagnostic and Statistical Manual of Mental
        Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness,
        organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular
        disease) or pregnant female subjects are excluded from study participation.
